351 related articles for article (PubMed ID: 19349565)
1. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.
Liberman JN; Berger JE; Lewis M
Arch Pediatr Adolesc Med; 2009 Apr; 163(4):357-64. PubMed ID: 19349565
[TBL] [Abstract][Full Text] [Related]
2. Use of pharmacologic agents for treatment of diabetes mellitus, dyslipidemia, and hypertension in children and adolescents.
Daniels SR
Arch Pediatr Adolesc Med; 2009 Apr; 163(4):389-91. PubMed ID: 19349572
[No Abstract] [Full Text] [Related]
3. Trends in the prevalence of chronic medication use in children: 2002-2005.
Cox ER; Halloran DR; Homan SM; Welliver S; Mager DE
Pediatrics; 2008 Nov; 122(5):e1053-61. PubMed ID: 18977954
[TBL] [Abstract][Full Text] [Related]
4. [How many and who are receiving medication for diabetes mellitus?].
Strøm H; Engeland A; Eriksen E; Sakshaug S; Rønning M
Tidsskr Nor Laegeforen; 2006 Mar; 126(6):768-70. PubMed ID: 16541171
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence and pharmacotherapy of diabetes mellitus in primary care].
Lehnert H; Wittchen HU; Pittrow D; Bramlage P; Kirch W; Böhler S; Höfler M; Ritz E
Dtsch Med Wochenschr; 2005 Feb; 130(7):323-8. PubMed ID: 15712019
[TBL] [Abstract][Full Text] [Related]
6. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden.
Nilsson PM; Gudbjörnsdottir S; Eliasson B; Cederholm J;
J Hum Hypertens; 2003 Jan; 17(1):37-44. PubMed ID: 12571615
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
Cortez-Dias N; Martins S; Belo A; Fiuza M;
Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
[TBL] [Abstract][Full Text] [Related]
8. Trends in psychotropic medication costs for children and adolescents, 1997-2000.
Martin A; Leslie D
Arch Pediatr Adolesc Med; 2003 Oct; 157(10):997-1004. PubMed ID: 14557161
[TBL] [Abstract][Full Text] [Related]
9. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
Scholze J; Lilienthal W; Bramlage P
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive medication use among US adults with hypertension.
Gu Q; Paulose-Ram R; Dillon C; Burt V
Circulation; 2006 Jan; 113(2):213-21. PubMed ID: 16391156
[TBL] [Abstract][Full Text] [Related]
11. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006.
Casscells SW; Granger E; Swedorske J; Goldhammer R; Shaheen M; Dorris J; Hong A; Wiktor M
Am J Ther; 2008; 15(3):198-205. PubMed ID: 18496256
[TBL] [Abstract][Full Text] [Related]
12. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
[TBL] [Abstract][Full Text] [Related]
13. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
[TBL] [Abstract][Full Text] [Related]
14. Positive change in the utilization of antihypertensive and lipid-lowering drugs among adult CHD patients in Finland: results from a large national database between 2000 and 2006.
Ahola TL; Kantola IM; Puukka P; Kattainen A; Klaukka T; Reunanen A; Jula AM
Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):477-85. PubMed ID: 20220527
[TBL] [Abstract][Full Text] [Related]
15. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.
; Liese AD; D'Agostino RB; Hamman RF; Kilgo PD; Lawrence JM; Liu LL; Loots B; Linder B; Marcovina S; Rodriguez B; Standiford D; Williams DE
Pediatrics; 2006 Oct; 118(4):1510-8. PubMed ID: 17015542
[TBL] [Abstract][Full Text] [Related]
16. Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995.
Wolf HK; Andreou P; Bata IR; Comeau DG; Gregor RD; Kephart G; MacLean DR; Sketris I
CMAJ; 1999 Sep; 161(6):699-704. PubMed ID: 10513276
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
McIntyre RS; Jerrell JM
Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
[TBL] [Abstract][Full Text] [Related]
18. Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong.
Lau GS; Chan JC; Chu PL; Tse DC; Critchely JA
Ann Pharmacother; 1996 Mar; 30(3):232-7. PubMed ID: 8833556
[TBL] [Abstract][Full Text] [Related]
19. [Can Danish health care registries provide data for specific drug-related hospital admissions in type 2 diabetes?].
Thomsen LA; Gundgaard J; Søndergaard B; Melander A; Sørensen J
Ugeskr Laeger; 2007 Aug; 169(33):2637-42. PubMed ID: 17725913
[TBL] [Abstract][Full Text] [Related]
20. Changing trends in antihypertensive therapy in two New England communities during the 1980s.
Hume AL; Barbour MM; Willey CJ; Assaf AR; Lapane KL; Carleton RA
Pharmacotherapy; 1993; 13(3):244-51. PubMed ID: 8100629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
